The DOI matches its Crossref record; 424 of the 424 references it cites were found in a registry or an index.
Cellular and molecular mechanisms of kidney fibrosis
Abstract
Renal fibrosis is the final pathological process common to any ongoing, chronic kidney injury or maladaptive repair. It is considered as the underlying pathological process of chronic kidney disease (CKD), which affects more than 10% of world population and for which treatment options are limited. Renal fibrosis is defined by excessive deposition of extracellular matrix, which disrupts and replaces the functional parenchyma that leads to organ failure. Kidney's histological structure can be divided into three main compartments, all of which can be affected by fibrosis, specifically termed glomerulosclerosis in glomeruli, interstitial fibrosis in tubulointerstitium and arteriosclerosis and perivascular fibrosis in vasculature. In this review, we summarized the different appearance, cellular origin and major emerging processes and mediators of fibrosis in each compartment. We also depicted and discussed the challenges in translation of anti-fibrotic treatment to clinical practice and discuss possible solutions and future directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–424 of 424
Ferenbach, D. A., & Bonventre, J. V. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000218 · Cited by 32
Muruve, D. A., Mann, M. C., Chapman, K., Wong, J. F., Ravani, P., Page, S. A., & Benediktsson, H. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0669-4 · Cited by 32
Dendritic cells in progressive renal disease: some answers, many questions
Kitching, A. R. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu076 · Cited by 31
Overcoming Barriers in Kidney Health—Forging a Platform for Innovation
Linde, P. G., Archdeacon, P., Breyer, M. D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015090976 · Cited by 31
Okamoto, T., Sasaki, S., Yamazaki, T., et al. (2014) · Nephron Experimental Nephrology · doi:10.1159/000357356 · Cited by 30
Is kidney injury a reversible process?
Chatziantoniou, C., & Dussaule, J. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3282f1bb69 · Cited by 30
Johnstone, D. B., Ikizler, O., Zhang, J., & Holzman, L. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067839 · Cited by 30
Liang, N., Kurihara, H., de Vega, S., Ichikawa‐Tomikawa, N., Xu, Z., Nonaka, R., Kazuno, S., Yamada, Y., Miner, J. H., & Arikawa‐Hirasawa, E. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.006 · Cited by 30
Luque, Y., Lenoir, O., Bonnin, P., Hardy, L. M., Chipont, A., Placier, S., Vandermeersch, S., Xu, Y., Robin, B., Lazareth, H., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016090960 · Cited by 30
The renal benefits of a healthy lifestyle
de Francisco, Á. L. M., Fresnedo, G. F., Palomar, R., Piñera, C., & Arias, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09901.x · Cited by 29
Renal fibrosis: Insight from proteomics in animal models and human disease
Klein, J., Kavvadas, P., Prakoura, N., Karagianni, F., Schanstra, J. P., Bascands, J., & CHARONIS, A. S. (2010) · PROTEOMICS · doi:10.1002/pmic.201000380 · Cited by 29
Wang, S., Zhang, C., Wang, J., Yang, C., Xu, M., Rong, R., Zhu, T., & Zhu, D. (2017) · Journal of Immunology Research · doi:10.1155/2017/8746303 · Cited by 29
Hepatocyte growth factor: A regulator of extracellular matrix genes in mouse mesangial cells
Laping, N. J., Olson, B. A., Ho, T. F., Ziyadeh, F. N., & Albrightson, C. R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00398-6 · Cited by 28
Shimo, T., Adachi, Y., Yamanouchi, S., Tsuji, S., Kimata, T., Umezawa, K., Okigaki, M., Takaya, J., Ikehara, S., & Kaneko, K. (2013) · American Journal of Nephrology · doi:10.1159/000348803 · Cited by 27
A Novel, Dual Role of CCN3 in Experimental Glomerulonephritis
van Roeyen, C. R. C., Boor, P., Borkham‐Kamphorst, E., Rong, S., Kunter, U., Martin, I. V., Kaitovic, A., Fleckenstein, S., Perbal, B., Trautwein, C., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.01.031 · Cited by 26
Self-citationHIPK2 is a new drug target for anti-fibrosis therapy in kidney disease
Nugent, M. M., Lee, K., & He, C. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00132 · Cited by 26
Lifestyle modification and progressive renal failure
Ritz, E., & Schwenger, V. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00439.x · Cited by 26
Numb contributes to renal fibrosis by promoting tubular epithelial cell cycle arrest at G2/M
Zhu, F., Liu, W., Li, T., Wan, J., Tian, J., Zhou, Z., Li, H., Liu, Y., Hou, F. F., & Nie, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8238 · Cited by 26
Lee, D., Shenoy, S., Nigatu, Y., & Plotkin, M. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088417 · Cited by 23
Editorial: Organ Fibrosis: Triggers, Pathways, and Cellular Plasticity
Mutsaers, H. A. M., & Olinga, P. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00055 · Cited by 22
Thrombotic Microangiopathies: From Animal Models to Human Disease and Cure
Caprioli, J., Remuzzi, G., & Noris, M. (2011) · Contributions to nephrology · doi:10.1159/000314579 · Cited by 18
Bing, P., Maode, L., Li, F., & he, S. T. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.07.015 · Cited by 15
Drug discovery in focal and segmental glomerulosclerosis
Pullen, N., & Fornoni, A. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.058 · Cited by 14
EP4: a new piece in the fibrotic puzzle
Boor, P. (2012) · Kidney International · doi:10.1038/ki.2012.125 · Cited by 11
Self-citation
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold
Bülow, R. D., & Boor, P. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419849388 · Cited by 406
Self-citationDuni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D., & Dounousi, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153711 · Cited by 382
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Panizo, S., Martínez-Arias, L., Alonso-Montes, C., Cannata, P., Martín-Carro, B., Fernández-Martín, J. L., Naves-Díaz, M., Carrillo-López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 372
TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target
Choi, E.-H., & Park, S.-J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01019-8 · Cited by 330
Metadata
- Authors
- Djudjaj, S., & Boor, P.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 65
- Pages
- 16-36
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2809667088
- Cited by
- 475
- References
- 424
- FWCI
- 21.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.